These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30803206)

  • 1. Determining Risk Factors for Gastric and Esophageal Cancers between 2009-2015 in East-Azarbayjan, Iran Using Parametric Survival Models.
    Zarean E; Amini P; Yaseri M; Hajihosseini M; Azimi T; Mahmoudi M
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):443-449. PubMed ID: 30803206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model.
    Zarean E; Azizmohammad Looha M; Amini P; Mahmoudi M; Azimi T
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1677-1683. PubMed ID: 29938465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining Overall Survival and Risk Factors in Esophageal Cancer Using Censored Quantile Regression.
    Zarean E; Mahmoudi M; Azimi T; Amini P
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3081-3086. PubMed ID: 30485945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal cancer in Iran; a population-based study regarding adequacy of cancer surgery and overall survival.
    Harirchi I; Kolahdoozan S; Hajizadeh S; Safari F; Sedighi Z; Nahvijou A; Mir MR; Mousavi SM; Zendehdel K
    Eur J Surg Oncol; 2014 Mar; 40(3):352-7. PubMed ID: 24238763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran.
    Samadi F; Babaei M; Yazdanbod A; Fallah M; Nouraie M; Nasrollahzadeh D; Sadjadi A; Derakhshan MH; Shokuhi B; Fuladi R; Malekzadeh R
    Arch Iran Med; 2007 Jan; 10(1):32-7. PubMed ID: 17198451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagus or stomach? The seventh TNM classification for Siewert type II/III junctional adenocarcinoma.
    Hasegawa S; Yoshikawa T; Aoyama T; Hayashi T; Yamada T; Tsuchida K; Cho H; Oshima T; Yukawa N; Rino Y; Masuda M; Tsuburaya A
    Ann Surg Oncol; 2013 Mar; 20(3):773-9. PubMed ID: 23224137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
    Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
    Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients.
    Esayas Lelisho M; Akessa GM; Kifle Demissie D; Fikadu Yermosa S; Andargie SA; Tareke SA; Pandey D
    J Gastrointest Cancer; 2023 Mar; 54(1):104-116. PubMed ID: 35064523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in gastric cancer using log-normal censored regression model.
    Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR
    Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality therapy of localized gastric and esophageal cancers.
    Das P; Fukami N; Ajani JA
    J Natl Compr Canc Netw; 2006 Apr; 4(4):375-82. PubMed ID: 16569390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.
    de Heer EC; Hulshoff JB; Klerk D; Burgerhof JGM; de Groot DJA; Plukker JTM; Hospers GAP
    Ann Surg Oncol; 2017 Jul; 24(7):1811-1820. PubMed ID: 28188501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome.
    Lee JS; Ahn JY; Choi KD; Song HJ; Kim YH; Lee GH; Jung HY; Ryu JS; Kim SB; Kim JH; Park SI; Cho KJ; Kim JH
    Korean J Intern Med; 2016 Mar; 31(2):253-9. PubMed ID: 26864297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reliable risk score for stage IV esophagogastric cancer.
    Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
    Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient education-level affects treatment allocation and prognosis in esophageal- and gastroesophageal junctional cancer in Sweden.
    Linder G; Sandin F; Johansson J; Lindblad M; Lundell L; Hedberg J
    Cancer Epidemiol; 2018 Feb; 52():91-98. PubMed ID: 29278841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer.
    Chang YL; Tsai YF; Chao YK; Wu MY
    Qual Life Res; 2016 Feb; 25(2):465-475. PubMed ID: 26238649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Survival Models for Analyzing Prognostic Factors in Gastric Cancer Patients.
    Habibi D; Rafiei M; Chehrei A; Shayan Z; Tafaqodi S
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):749-753. PubMed ID: 29582630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion.
    Yamaguchi S; Morita M; Yamamoto M; Egashira A; Kawano H; Kinjo N; Tsujita E; Minami K; Ikebe M; Ikeda Y; Kunitake N; Toh Y
    Ann Surg Oncol; 2018 Oct; 25(11):3280-3287. PubMed ID: 30051363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical comparison of survival models for analysis of cancer data.
    Moghimi-Dehkordi B; Safaee A; Pourhoseingholi MA; Fatemi R; Tabeie Z; Zali MR
    Asian Pac J Cancer Prev; 2008; 9(3):417-20. PubMed ID: 18990013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of multimodality therapy for resectable esophageal cancer.
    Meneu-Diaz JC; Blazquez LA; Vicente E; Nuño J; Quijano Y; Lopez-Hervás P; Devesa M; Fresneda V
    Am J Surg; 2000 Jun; 179(6):508-13. PubMed ID: 11004342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.